Discontinuation of Chronic Benzodiazepine Use Among Adults in the United States.

ABSTRACT:

Background

Guidelines recommend most benzodiazepine (BZD) treatment be short-term, though chronic BZD use is increasing.

Objective

Determine the rate of BZD discontinuation among chronic users and identify patient- and provider-level factors associated with discontinuation.

Design, setting, and participants

A retrospective cohort study using nationwide insurance claims data from 2014 to 2016 of US adults ≥ 18 years old with chronic BZD use (i.e., > 120 days) during the baseline year.

Main outcomes and measures

The primary outcome was BZD discontinuation among chronic users after 1 year of follow-up. A series of multilevel logistic regression models examined the association of BZD discontinuation with patient and provider characteristics. Covariates included pat

SUBMITTER: Gerlach LB 

PROVIDER: S-EPMC6712149 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature